Table 3

Baseline measures of osteoarthritis and related impairment.

Variable
Sequence A SAMe – Celecoxib (N = 28)
Sequence B Celecoxib – SAMe (N = 29)



N (%)
N (%)

Tenderness in Knee*
None
5 (18.5%)
6 (20.7%)
Slight
9 (33.3%)
7 (24.1%)
Moderate
13 (48.1%)
14 (48.3%)
Severe
0 (0.0%)
2 (6.9%)

Swelling in Knee*

None
15 (55.6%)
6 (20.7%)
Slight
10 (37.0%)
17 (58.6%)
Moderate
2 (7.4%)
6 (20.7%)

Fluid in Knee Joint*

None
22 (81.5%)
20 (69.0%)
Slight
3 (11.1%)
7 (24.1%)
Moderate
2 (7.4%)
2 (6.9%)
Redness in Knee*
0 (0.0%)
1 (3.4%)

Walking Distance**

<1 block without pain
3 (10.7%)
3 (10.3%)
<1 block with pain
1 (3.6%)
4 (13.8%)
<1 mile without pain
1 (3.6%)
1 (3.4%)
<1 mile with pain
6 (21.4%)
7 (24.1%)
>1 mile without pain
6 (21.4%)
4 (13.8%)
>1 mile with pain
12 (42.9%)
13 (44.8%)

Basic ADL – Need Assistance with

Dressing
1 (3.6%)
0 (0.0%)
Transferring
0 (0.0%)
0 (0.0%)
Bathing
0 (0.0%)
0 (0.0%)
Toileting
0 (0.0%)
0 (0.0%)

Advanced ADL – Difficulty with

Light housework
1 (3.6%)
4 (13.8%)
Heavy housework
9 (32.1%)
16 (55.2%)
Stooping / crouching
26 (92.9%)
27 (93.1%)
Getting in/out of car
17 (60.7%)
18 (62.1%)

* One patient in Sequence A had missing data. ** Multiple responses per patient were allowed. There were no statistically significant differences between the two sequences.

Najm et al. BMC Musculoskeletal Disorders 2004 5:6   doi:10.1186/1471-2474-5-6